BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26724730)

  • 1. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
    El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
    Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.
    Lončar B; Perin N; Mioč M; Boček I; Grgić L; Kralj M; Tomić S; Stojković MR; Hranjec M
    Eur J Med Chem; 2021 May; 217():113342. PubMed ID: 33751978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.
    Kamal A; Ramakrishna G; Raju P; Rao AV; Viswanath A; Nayak VL; Ramakrishna S
    Eur J Med Chem; 2011 Jun; 46(6):2427-35. PubMed ID: 21481986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective synthesis of benzimidazoles-imidazo[1,2-a]pyrazine conjugates: A comparative study of mono-and bis-benzimidazoles for antitumor activity.
    Singh I; Luxami V; Paul K
    Eur J Med Chem; 2019 Oct; 180():546-561. PubMed ID: 31344614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
    Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P
    Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure activity relationship studies of imidazo[1,2-a]pyrazine derivatives against cancer cell lines.
    Myadaraboina S; Alla M; Saddanapu V; Bommena VR; Addlagatta A
    Eur J Med Chem; 2010 Nov; 45(11):5208-16. PubMed ID: 20832916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
    Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines. Part 2.
    Jung MH; El-Gamal MI; Abdel-Maksoud MS; Sim T; Yoo KH; Oh CH
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4362-7. PubMed ID: 22647720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.
    Bellet V; Lichon L; Arama DP; Gallud A; Lisowski V; Maillard LT; Garcia M; Martinez J; Masurier N
    Eur J Med Chem; 2017 Jan; 125():1225-1234. PubMed ID: 27871038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer.
    Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y
    Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.
    El-Gamal MI; Choi HS; Cho HG; Hong JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2011 Nov; 344(11):745-54. PubMed ID: 21954060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies.
    Koh EJ; El-Gamal MI; Oh CH; Lee SH; Sim T; Kim G; Choi HS; Hong JH; Lee SG; Yoo KH
    Eur J Med Chem; 2013; 70():10-21. PubMed ID: 24128410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiproliferative evaluation of some new amidino-substituted bis-benzothiazolyl-pyridines and pyrazine.
    Racané L; Kraljević Pavelić S; Ratkaj I; Stepanić V; Pavelić K; Tralić-Kulenović V; Karminski-Zamola G
    Eur J Med Chem; 2012 Sep; 55():108-16. PubMed ID: 22841279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6 (1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents.
    Chitti S; Singireddi S; Santosh Kumar Reddy P; Trivedi P; Bobde Y; Kumar C; Rangan K; Ghosh B; Sekhar KVGC
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2551-2558. PubMed ID: 31420269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity.
    Baccon-Sollier PL; Malki Y; Maye M; Ali LMA; Lichon L; Cuq P; Vincent LA; Masurier N
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):935-949. PubMed ID: 32249633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and molecular docking study of 3H-imidazole[4,5-c]pyridine derivatives as CDK2 inhibitors.
    Wu YZ; Ying HZ; Xu L; Cheng G; Chen J; Hu YZ; Liu T; Dong XW
    Arch Pharm (Weinheim); 2018 Jun; 351(6):e1700381. PubMed ID: 29708285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of dehydroepiandrosterone-fused thiazole, imidazo[2,1-b]thiazole, pyridine steroidal analogues.
    Zhang BL; Song LX; Li YF; Li YL; Guo YZ; Zhang E; Liu HM
    Steroids; 2014 Feb; 80():92-101. PubMed ID: 24355392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.